← Back to Search

BP-ICAN for High Blood Pressure (CHAR2 Trial)

N/A

Recruiting

Led By Denise A Dillard, PhD

Research Sponsored by Southcentral Foundation

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months, 6 months, and 12 months

Awards & highlights

CHAR2 Trial Summary

This trial is designed to see if monitoring blood pressure at home improves the management of hypertension for Alaska Native and American Indian people.

CHAR2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months, 6 months, and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months, 6 months, and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months, 6 months, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Individual-level: within-person change in systolic blood pressure

Provider-level: frequency of antihypertensive medication adjustments

System-level: change in systolic blood pressure for all patients with hypertension

CHAR2 Trial Design

2Treatment groups

Active Control

Group I: BP-ICANActive Control1 Intervention

Participants in the BP-ICAN arm will receive a home blood pressure monitor to be used twice daily for 12 months. Participants' home blood pressure measurements will be shared with their provider and participants will receive a series of text messages including topics on the importance of managing hypertension, reminders to measure blood pressure with their device, and motivational messages on diet and exercise.

Group II: ControlActive Control1 Intervention

Participants in the control arm will receive care as usual for the treatment of hypertension

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Southcentral FoundationLead Sponsor

6 Previous Clinical Trials

6,350 Total Patients Enrolled

Washington State UniversityOTHER

101 Previous Clinical Trials

56,390 Total Patients Enrolled

Denise A Dillard, PhDPrincipal InvestigatorSouthcentral Foundation

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open slots available in this research program?

"This medical trial, which was first made public on February 19th 2019, is actively searching for participants. The information has been recently modified as of May 9th 2022 according to clinicaltrials.gov."

Answered by AI

What is the uppermost participant limit of this investigation?

"Affirmative. According to the information on clinicaltrials.gov, recruitment for this medical trial is currently underway. This research endeavour was initially posted on February 19th 2019 and last updated on May 9th 2022; 324 volunteers are required from 2 locations."

Answered by AI

Recent research and studies

CirculationJournal

Rising Tide of Cardiovascular Disease in American Indians

Howard, Barbara V., Elisa T. Lee, Linda D. Cowan, Richard B. Devereux, James M. Galloway, Oscar T. Go, William James Howard, et al.. 1999. “Rising Tide of Cardiovascular Disease in American Indians”. Circulation. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/01.cir.99.18.2389.

Current Cardiovascular Risk ReportsJournal

Cardiovascular Disease Among Alaska Native Peoples

Jolly, Stacey E., Barbara V. Howard, and Jason G. Umans. 2013. “Cardiovascular Disease Among Alaska Native Peoples”. Current Cardiovascular Risk Reports. Springer Science and Business Media LLC. doi:10.1007/s12170-013-0362-5.

Neurologic ClinicsJournal

Stroke in Minorities

Trimble, Brian, and Lewis B. Morgenstern. 2008. “Stroke in Minorities”. Neurologic Clinics. Elsevier BV. doi:10.1016/j.ncl.2008.05.010.

BMC Family PracticeJournal